This application-based continuing pharmacy education activity will provide a “journal club format” discussion for pharmacists and student pharmacists ondelafloxacin, a fluoroquinolone recently approved by the FDA approved for skinand soft tissue infections. Join us to discuss the key trial leading to its approval as well as highlight clinical pearls to clarify its place in therapy for patients in your practice.
We’re Your Partner for Life Long Learning. With more than 25 years in the CE business, we create education and training, partner on your education ideas, and license our learning management system. How can we serve you?
This post is related to:
Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.
